Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Anna L. Kenchington & Ronald F. Lamont. (2017) Group B streptococcal immunisation of pregnant women for the prevention of early and late onset Group B streptococcal infection of the neonate as well as adult disease. Expert Review of Vaccines 16:1, pages 15-25.
Read now
Read now
Iwona Szymusik, Katarzyna Kosinska-Kaczynska, Andrzej Krolik, Magdalena Skurnowicz, Bronislawa Pietrzak & Miroslaw Wielgos. (2014) The usefulness of the universal culture-based screening and the efficacy of intrapartum prophylaxis of group B Streptococcus infection. The Journal of Maternal-Fetal & Neonatal Medicine 27:9, pages 968-970.
Read now
Read now
Articles from other publishers (38)
Filippo Carboni & Roberto Adamo. (2020) Structure-based glycoconjugate vaccine design: The example of Group B Streptococcus type III capsular polysaccharide. Drug Discovery Today: Technologies 35-36, pages 23-33.
Crossref
Crossref
Shunming Li, Guoming Wen, Xuelian Cao, Dan Guo, Zhenjiang Yao, Chuan'an Wu & Xiaohua Ye. (2018) Molecular characteristics of Streptococcus agalactiae in a mother-baby prospective cohort study: Implication for vaccine development and insights into vertical transmission. Vaccine 36:15, pages 1941-1948.
Crossref
Crossref
Filippo Carboni, Roberto Adamo, Monica Fabbrini, Riccardo De Ricco, Vittorio Cattaneo, Barbara Brogioni, Daniele Veggi, Vittoria Pinto, Irene Passalacqua, Davide Oldrini, Rino Rappuoli, Enrico Malito, Immaculada y Ros Margarit & Francesco Berti. (2017)
Structure of a protective epitope of group B
Streptococcus
type III capsular polysaccharide
. Proceedings of the National Academy of Sciences 114:19, pages 5017-5022.
Crossref
Crossref
Monica Fabbrini, Fabio Rigat, C. Daniela Rinaudo, Irene Passalaqua, Sceida Khacheh, Roberta Creti, Lucilla Baldassarri, Filippo Carboni, Giulia Anderloni, Roberto Rosini, Domenico Maione, Guido Grandi, John L. Telford & Immaculada Margarit. (2016)
The Protective Value of Maternal Group B
Streptococcus
Antibodies: Quantitative and Functional Analysis of Naturally Acquired Responses to Capsular Polysaccharides and Pilus Proteins in European Maternal Sera
. Clinical Infectious Diseases 63:6, pages 746-753.
Crossref
Crossref
Edmondo Campisi, Roberto Rosini, Wenjing Ji, Silvia Guidotti, Maricarmen Rojas-López, Guozhu Geng, Qiulian Deng, Huamin Zhong, Weidong Wang, Haiying Liu, Cassandra Nan, Immaculada Margarit & C. D. Rinaudo. (2016) Genomic Analysis Reveals Multi-Drug Resistance Clusters in Group B Streptococcus CC17 Hypervirulent Isolates Causing Neonatal Invasive Disease in Southern Mainland China. Frontiers in Microbiology 7.
Crossref
Crossref
Edmondo Campisi, C. Daniela Rinaudo, Claudio Donati, Mara Barucco, Giulia Torricelli, Morven S. Edwards, Carol J. Baker, Imma Margarit & Roberto Rosini. (2016) Serotype IV Streptococcus agalactiae ST-452 has arisen from large genomic recombination events between CC23 and the hypervirulent CC17 lineages. Scientific Reports 6:1.
Crossref
Crossref
Reinhard Berner. (2016) En route towards prevention of neonatal group B streptococcal disease. The Lancet Infectious Diseases 16:5, pages 509-510.
Crossref
Crossref
Joana Alves, Pedro Madureira, Maria Teresa Baltazar, Leandro Barros, Liliana Oliveira, Ricardo Jorge Dinis-Oliveira, Elva Bonifácio Andrade, Adília Ribeiro, Luís Mira Vieira, Patrick Trieu-Cuot, José Alberto Duarte, Félix Carvalho & Paula Ferreira. (2015) A Safe and Stable Neonatal Vaccine Targeting GAPDH Confers Protection against Group B Streptococcus Infections in Adult Susceptible Mice. PLOS ONE 10:12, pages e0144196.
Crossref
Crossref
Scott A. Sullivan & Christopher Goodier. 2015. Management of Labor and Delivery. Management of Labor and Delivery
376
415
.
Danny WH Ko, Yvonne Zurynski & Gwendolyn L Gilbert. (2015) Group B streptococcal disease and genotypes in Australian infants. Journal of Paediatrics and Child Health 51:8, pages 808-814.
Crossref
Crossref
B. Lu, D. Wang, H. Zhou, F. Zhu, D. Li, S. Zhang, Y. Shi, Y. Cui, L. Huang & H. Wu. (2015) Distribution of pilus islands and alpha-like protein genes of group B Streptococcus colonized in pregnant women in Beijing, China. European Journal of Clinical Microbiology & Infectious Diseases 34:6, pages 1173-1179.
Crossref
Crossref
Margarita Laczeski, Marina Novosak, Roxana Cannistraci Giolito, Ana Littvik, Jorge Paván, Viviana Villalba & Marta Vergara. (2015) Study of Serotypes, Susceptibility to Macrolide and Virulence and Resistance Molecular Profiles in Invasive Strains of <i>Streptococcus agalactiae</i> in Two Argentine Provinces. Advances in Microbiology 05:04, pages 230-243.
Crossref
Crossref
Francesco Berti, Edmondo Campisi, Chiara Toniolo, Laura Morelli, Stefano Crotti, Roberto Rosini, Maria Rosaria Romano, Vittoria Pinto, Barbara Brogioni, Giulia Torricelli, Robert Janulczyk, Guido Grandi & Immaculada Margarit. (2014) Structure of the Type IX Group B Streptococcus Capsular Polysaccharide and Its Evolutionary Relationship with Types V and VII. Journal of Biological Chemistry 289:34, pages 23437-23448.
Crossref
Crossref
L.M. Lambertsen, H. Ingels, H.C. Schønheyder & S. Hoffmann. (2014) Nationwide laboratory-based surveillance of invasive beta-haemolytic streptococci in Denmark from 2005 to 2011. Clinical Microbiology and Infection 20:4, pages O216-O223.
Crossref
Crossref
Jennifer R. Verani, Nancy L. Spina, Ruth Lynfield, William Schaffner, Lee H. Harrison, Amy Holst, Stepy Thomas, Jessica M. Garcia, Karen Scherzinger, Deborah Aragon, Susan Petit, Jamie Thompson, Lauren Pasutti, Roberta Carey, Lesley McGee, Emily Weston & Stephanie J. Schrag. (2014) Early-Onset Group B Streptococcal Disease in the United States. Obstetrics & Gynecology 123:4, pages 828-837.
Crossref
Crossref
Maureen E. Sims. (2014)
Legal Briefs: Late-Onset Group B
Streptococcus
Meningitis: Should It Happen in a Newborn Intensive Care Unit?
. NeoReviews 15:3, pages e104-e107.
Crossref
Crossref
Q. Bassat. (2013) Maternal immunization: An intelligent solution to reduce the hidden burden of group B streptococcus perinatal disease. Journal of Tropical Pediatrics 59:5, pages 333-337.
Crossref
Crossref
Pierrette Melin & Androulla Efstratiou. (2013) Group B streptococcal epidemiology and vaccine needs in developed countries. Vaccine 31, pages D31-D42.
Crossref
Crossref
Purificacion F. TumbagaAlistair G.S. Philip. (2013) Perinatal Group B Streptococcal Infections: Current Status and Future Directions. NeoReviews 14:6, pages e306-e316.
Crossref
Crossref
Anita H.J. van den Biggelaar & William S. Pomat. (2013) Immunization of newborns with bacterial conjugate vaccines. Vaccine 31:21, pages 2525-2530.
Crossref
Crossref
Kari Auranen, Hanna Rinta‐Kokko & M. Elizabeth Halloran. (2013) Estimating Strain‐Specific and Overall Efficacy of Polyvalent Vaccines Against Recurrent Pathogens From a Cross‐Sectional Study. Biometrics 69:1, pages 235-244.
Crossref
Crossref
E. R. Martins, A. Andreu, J. Melo-Cristino & M. Ramirez. (2013) Distribution of Pilus Islands in Streptococcus agalactiae That Cause Human Infections: Insights into Evolution and Implication for Vaccine Development. Clinical and Vaccine Immunology 20:2, pages 313-316.
Crossref
Crossref
S. Bellais, A. Six, A. Fouet, M. Longo, N. Dmytruk, P. Glaser, P. Trieu-Cuot & C. Poyart. (2012) Capsular Switching in Group B Streptococcus CC17 Hypervirulent Clone: A Future Challenge for Polysaccharide Vaccine Development. Journal of Infectious Diseases 206:11, pages 1745-1752.
Crossref
Crossref
E. R. Martins, J. Melo-Cristino & M. Ramirez. (2012) Dominance of Serotype Ia among Group B Streptococci Causing Invasive Infections in Nonpregnant Adults in Portugal. Journal of Clinical Microbiology 50:4, pages 1219-1227.
Crossref
Crossref
Mariela Segura. (2012)
Fisher Scientific Award Lecture — The capsular polysaccharides of Group B
Streptococcus
and
Streptococcus suis
differently modulate bacterial interactions with dendritic cells
1
This article is based on an Award Lecture by Dr. Mariela Segura at the 61st Annual Meeting of the Canadian Society of Microbiologists in St. John’s, Newfoundland, on 23 June 2011. Dr. Segura was the recipient of the 2011 Fisher Scientific Award, a national award sponsored by Fisher Scientific to recognize excellence in microbiology research.
. Canadian Journal of Microbiology 58:3, pages 249-260.
Crossref
Crossref
Shruti Agrawal & Simon Nadel. (2011) Acute Bacterial Meningitis in Infants and Children. Pediatric Drugs 13:6, pages 385-400.
Crossref
Crossref
Olaf Schneewind & Dominique Missiakas. (2011) Structural vaccinology to thwart antigenic variation in microbial pathogens. Proceedings of the National Academy of Sciences 108:25, pages 10029-10030.
Crossref
Crossref
Beatrice M. Senn, Zehra Visram, Andreas L. Meinke, Christina Neubauer, Dieter Gelbmann, Jan Sinzinger, Markus Hanner, Urban Lundberg, Heike Boisvert, Dieter Reinscheid, Alexander von Gabain & Eszter Nagy. (2011) Monoclonal antibodies targeting different cell wall antigens of group B streptococcus mediate protection in both Fc-dependent and independent manner. Vaccine 29:24, pages 4116-4124.
Crossref
Crossref
C. Viala & P. Deruelle. (2011) Pour la pratique systématique du dépistage du streptocoque B dans le suivi de grossesse. Gynécologie Obstétrique & Fertilité 39:5, pages 321-323.
Crossref
Crossref
Jenny Fernebro. (2011) Fighting bacterial infections—Future treatment options. Drug Resistance Updates 14:2, pages 125-139.
Crossref
Crossref
Zain A Al-Safi, Valerie I Shavell & Bernard Gonik. (2011) Vaccination in Pregnancy. Women's Health 7:1, pages 109-119.
Crossref
Crossref
Andreas L. Meinke, Beatrice M. Senn, Zehra Visram, Tam?s Z. Henics, Duc Bui Minh, Wolfgang Sch?ler, Christina Neubauer, Dieter Gelbmann, Birgit Noiges, Jan Sinzinger, Markus Hanner, Shailesh Dewasthaly, Urban Lundberg, Knut Hordnes, Helga Masoud, Paul Sevelda, Alexander von Gabain & Eszter Nagy. (2010) Immunological fingerprinting of group B streptococci: From circulating human antibodies to protective antigens. Vaccine 28:43, pages 6997-7008.
Crossref
Crossref
Michael S. Bronze & James B. Dale. (2010) Progress in the Development of Effective Vaccines to Prevent Selected Gram-Positive Bacterial Infections. The American Journal of the Medical Sciences 340:3, pages 218-225.
Crossref
Crossref
Dace V. Madore, Bruce D. Meade, Fran Rubin, Carolyn Deal & Freyja Lynn. (2010) Utilization of serologic assays to support efficacy of vaccines in nonclinical and clinical trials: Meeting at the Crossroads. Vaccine 28:29, pages 4539-4547.
Crossref
Crossref
Jennifer R. Verani & Stephanie J. Schrag. (2010) Group B Streptococcal Disease in Infants: Progress in Prevention and Continued Challenges. Clinics in Perinatology 37:2, pages 375-392.
Crossref
Crossref
Anna C Seale, Michael Mwaniki, Charles RJC Newton & James A Berkley. (2009) Maternal and early onset neonatal bacterial sepsis: burden and strategies for prevention in sub-Saharan Africa. The Lancet Infectious Diseases 9:7, pages 428-438.
Crossref
Crossref
Joyce M. Koenig & William J. Keenan. (2009) Group B Streptococcus and Early-Onset Sepsis in the Era of Maternal Prophylaxis. Pediatric Clinics of North America 56:3, pages 689-708.
Crossref
Crossref
Lakshmi Rajagopal. (2009) Understanding the regulation of Group B Streptococcal virulence factors. Future Microbiology 4:2, pages 201-221.
Crossref
Crossref